Who backs Diagonal Therapeutics?
17 investors| Investor | Type |
|---|---|
| Lightspeed Venture Partners | Venture capital |
| Viking Global Investors | Asset manager |
| RA Capital Management | Asset manager |
| Logos Capital | Hedge fund |
| Frazier Healthcare Partners | Venture capital |
| Atlas Venture | Other |
| Deep Track Capital | Venture capital |
| EcoR1 Capital | Hedge fund |
| Woodline Partners | Hedge fund |
| Balyasny Asset Management | Hedge fund |
| + 7 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Diagonal Therapeutics investors
17 investors are on record for Diagonal Therapeutics, including Lightspeed Venture Partners, Viking Global Investors, RA Capital Management and Logos Capital. By type, the record holds 5 hedge funds, 3 venture capital firms and 2 asset managers. The Series B in Jan 2026 drew 16 investors.
Free account
More of Diagonal Therapeutics with a free account
- ·The complete investor list: 17 names
- ·Watch Diagonal Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 17 firms already write checks for companies like Diagonal Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View